Development of conditions for analytical diagnosis of poisoning with clopidogrel

DOI: https://doi.org/10.29296/25419218-2022-06-02
Issue: 
6
Year: 
2022

L.S. Anosovа
Donetsk National Medical University named after M. Gorky, 16, Ilyich Ave., Donetsk, 283003, DNR

Introduction. Clopidogrel bisulfate (Clopidogrel) is one of the main drugs for the treatment of various cardiovascular diseases (acute coronary syndrome, ischemic stroke, transient ischemic attack, peripheral artery disease, etc.). Especially, this drug is very relevant in the treatment of COVID-19. Clopidogrel has repeatedly been the cause of lethal poisoning, and cases of clopidogrel being used for suicide are very common in China. According to the studied literature data, the analysis of this drug in the biological material is not presented. Objective: The aim of the research was to establish the distinctive ability of conventional methods of isolating medicinal substances from biological material in relation to clopidogrel in chemical and toxicological analysis (CTA). Material and methods. The study was carried out with model samples of pig liver that had not undergone putrefactive changes, which contained the studied drug. Detection and quantification of clopidogrel in extracts were carried out using thin-layer chromatography (TLC) and UV spectrophotometry. Results. The isolation efficiency of clopidogrel according to the method of A.A. Vasilyeva was 57.75±5.08%, according to the method of V.P. Kramarenko – 64.23±5.44%. When using the isolation method of A.A. Vasilyeva, the detection limit of clopidogrel was 1.04%, according to the method of V.P. Kramarenko – 1.09%. The limit of quantitative determination of clopidogrel according to the method of A.A. Vasilyeva is 3.31%, according to the method of V.P. Kramarenko – 3.34%, respectively. Conclusion. For analytical diagnostics in case of clopidogrel poisoning, TLC screening and UV spectrophotometric determination must be carried out with preliminary TLC purification. Isolation of clopidogrel with water acidified with ethyl alcohol (the Stas-Otto method) does not work. The effectiveness of isolating the drug by the method of V.P. Kramarenko is 64.23±5.44%. The greatest selectivity of the UV spectrophotometric method for determining clopidogrel in biological material in relation to matrix components was provided by the method of isolation with water acidified with sulfuric acid (V.P. Kramarenko's method).
Keywords: 
clopidogrel
analytical diagnostics
general isolation methods
TLC
UV spectrophotometry.
References: 
  1. Physicians` Desk Reference. 54th ed. Montvale: Medical Economics. 2000; 2756–8.
  2. Clarke’s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material: 4th ed. ed. by A. C. Moffat, M. D. Osselton, B. Widdop. London: The Pharm. Press. 2011; 2609.
  3. Capodanno D., Alberts M.J., Angiolillo D.J. Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease. Nature Reviews Cardiology. 2016; 13: 609–22.
  4. Bonello L. et al. Clopidogrel Response Variability: Etiology and Clinical Relevance. Current Cardiovascular Risk Reports. 2015; 9 (3): 1–9.
  5. Nijenh V.J. uis et al. Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation N. Engl. J. Med. 2020; 382 (18): 1696–707. DOI: 10.1056/NEJMoa1915152 .
  6. Nairooz R. et al. Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. International J. of Cardiology. 2017; 229 (15): 82–9.
  7. Trenk D., Zolk O., Fromm M.F. et al. Personalizing antiplatelet therapy with clopidogrel. Clin. Pharmacol. Ther. 2012; 92: 476–85.
  8. Goluhova E.Z., Grigoryan M.V., Ryabinina M.N. Sovremennye aspekty farmakogenetiki klopidogrela i ego klinicheskoe znachenie. Kreativnaya kardiologiya. 2014; 3: 39–52 (in Russian)
  9. Anosova L.S. Raspredelenie klopidogrela v organah otravlennyh zhivotnyh. Farmaciya. 2021; 70 (6): 31–6. DOI: 10.29296/25419218-2021-06-06 (in Russian)
  10. Fukusako T. et al. Case of thrombotic thrombocytopenic purpura associated with clopidogrel. Rinsho Shinkeigaku. 2007; 47 (10): 635–8.
  11. Borderías C.L., Garrapiz L.J., Caballero G. Pulmonary haemorrhage and haemothorax after massive ingestion of clopidogrel as a suicide attempt. Arch. Bronconeumol. 2009; 45 (11): 570–1. DOI: 10.1016/j.arbres.2009.06.009.
  12. Kocabay G., Okçular I., Akkaya V., Güler K. Suicide attempt with clopidogrel. Hum. Exp. Toxicol. 2006; 25 (12): 731–4.
  13. Al Asmar R., Zeid F. Acute Hemothorax Causing Hemorrhagic Shock Following Small-bore Thoracocentesis in a Patient on Clopidogrel: A Case Report and Literature Review. Cureus. 2020; 12 (3): e7431. DOI: 10.7759/cureus.7431.
  14. Bondar V.S., Anosova L.S. Visokoefektivna rіdinna hromatografіya v analіzі klopіdogrelyu. Farmacevt. chasop. 2012; 4 (24): 73–8 (in Ukrain).
  15. Krasnyh L.M., Karlickaya A.A. Kolichestvennoe opredelenie klopidogrela v plazme krovi metodom VEZHKH s mass-spektrometricheskim detektorom. Biomedicina. 2011; 4: 96–7 (in Russian)
  16. Lenka Vocilkovaa, Radka Opatrilova and Vladimir Srameka. Determination of Clopidogrel by Chromatography. Current Pharmaceutical Analysis. 2009; 5 (4): 1–8.
  17. Lagorce P., Perez Y., Ortiz J., Necciari J., Bressollec F. Assay method for the carboxylic acid metabolite of clopidogrel in human plasma by gas chromatography–mass spectrometry. J. Chromatogr. B. 2008; 720 (1–2): 107–17.
  18. Takahashi M., Pang H., Kawabata K., Farid N.A., Kurihara A. Stabilization of the clopidogrel active metabolite in whole blood and its assay in human plasma by LC/MS/MS J. Pharm. Biomed. Anal. 2008; 48 (4): 1219–24.
  19. 19. Patel N.K., Subbaiah G., Shah H., Kundlik M., Shrivastav P.S. Rapid LC-ESI-MS-MS method for the simultaneous determination of clopidogrel and its carboxylic acid metabolite in human plasma. J. Chromatogr. Sci. 2008; 46 (10): 867–75.
  20. Gosudarstvennaya Farmakopeya Rossijskoj Federacii, XIV izd., tom I, OFS.1.1.0022.18 «Mernaya posuda». [Elektronnoe izdanie]. Rezhim dostupa: https://femb.ru/record/pharmacopea14. [Data obrashcheniya 12 iyunya, 2022] (in Russian).
  21. Bondar' V.S., Anosova L.S., Shovkovaya Z.V. Izolirovanie klopidogrelya i ego metabolita iz biomateriala. Farmaciya Kazahstana. 2013; 7: 34–7 (in Russian)
  22. Bondar' V.S., Anosova L.S. Rozrobka metodіv іdentifіkacії klopіdogrelyu, pridatnih dlya hіmіko-toksikologіchnogo analіzu. Farmacіya Ukraїni. Poglyad u majbutnє: materіali VIІ Nac. z’їzdu farmacevtіv Ukraїni, 15–17 veres. 2010 r., Harkіv. H. 2010; 1: 137 (in Ukrain)
  23. Bondar' V.S., Anosova L.S., Shovkova Z.V. Іdentifіkacіya klopіdogrelyu ta jogo metabolіtu za dopomogoyu metodu tonkosharovoї hromatografії. Ukr. med. al'm. 2013; 16 (1): 50–2 (in Ukrain)
  24. SOFT/AAFS Forensic Laboratory Guidelines. 2006; 24. [Электронный ресурс]. Available at: http://www.soft–tox.org/files/ Guidelines_2006_Final.pdf
  25. Gosudarstvennaya farmakopeya Rossijskoj Federacii. OFS.1.1.0012.15 «Validaciya analiticheskih metodik». MZ RF. XIII izd. T. 1. Moskva, 2015; 1470 (in Russian).